Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Banting Postdoctoral Fellowship Program

Direct Payment

$140,000.00

Non-invasive mapping of pulmonary vein to left atrium electrical conduction in patients with atrial fibrillation

FY 2018-19

Summary
Atrial fibrillation (AF) is the most common sustained abnormal heart rhythm (cardiac arrhythmia) and is characterized by a loss of coordinated electrical activity and therefore loss of coordinated contraction in the atria (the top chambers of the heart). It is estimated that one's lifetime risk of AF is 1 in 4, with projected increases in prevalence in the coming decades and therefore substantial public health implications given its associated morbidity and mortality. For patients in whom attempts to restore and maintain a normal (sinus) heart rhythm are pursued, two main options exist: antiarrhythmic medications and catheter ablation, the latter of which is more effective. Catheter ablation is generally a safe procedure, but it requires advancing catheters from peripheral blood vessels into the atria and delivering ablation lesions to specific areas to electrically disconnect the left atrium from the pulmonary veins (the latter have been shown to be important sources of triggers of this arrhythmia). When successful, the arrhythmia is no longer able to start and be sustained in the atria. However, recurrences of the arrhythmia are unfortunately not uncommon after ablation procedures. In cases when the arrhythmia recurs, physicians are currently unable to determine whether it is because the left atrium and pulmonary veins have reconnected (which is usually easily treated with high success rates) or if new triggers for the arrhythmia have arisen elsewhere in the heart (which is more difficult to treat with lower success rates). The only way to know currently is to repeat the procedure. We believe that a non-invasive alternative exists that relies on recently developed technology that merges complex analysis of cardiac electrical signals detected from the body's surface with cardiac imaging. If shown to be feasible and accurate, our proposed study could substantially impact how we counsel patients with this arrhythmia and how we perform repeat ablation procedures.
Program
Banting Postdoctoral Fellowship Program
Location
France
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
392403
Name
RAMIREZ Francisco D
Country
France
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Non-invasive mapping of pulmonary vein to left atrium electrical conduction in patients with atrial fibrillation
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Arrhythmia, Cardiac; Atrial Fibrillation; Catheter Ablation; Non-Invasive Mapping
Abstract
Atrial fibrillation (AF) is the most common sustained abnormal heart rhythm (cardiac arrhythmia) and is characterized by a loss of coordinated electrical activity and therefore loss of coordinated contraction in the atria (the top chambers of the heart). It is estimated that one's lifetime risk of AF is 1 in 4, with projected increases in prevalence in the coming decades and therefore substantial public health implications given its associated morbidity and mortality. For patients in whom attempts to restore and maintain a normal (sinus) heart rhythm are pursued, two main options exist: antiarrhythmic medications and catheter ablation, the latter of which is more effective. Catheter ablation is generally a safe procedure, but it requires advancing catheters from peripheral blood vessels into the atria and delivering ablation lesions to specific areas to electrically disconnect the left atrium from the pulmonary veins (the latter have been shown to be important sources of triggers of this arrhythmia). When successful, the arrhythmia is no longer able to start and be sustained in the atria. However, recurrences of the arrhythmia are unfortunately not uncommon after ablation procedures. In cases when the arrhythmia recurs, physicians are currently unable to determine whether it is because the left atrium and pulmonary veins have reconnected (which is usually easily treated with high success rates) or if new triggers for the arrhythmia have arisen elsewhere in the heart (which is more difficult to treat with lower success rates). The only way to know currently is to repeat the procedure. We believe that a non-invasive alternative exists that relies on recently developed technology that merges complex analysis of cardiac electrical signals detected from the body's surface with cardiac imaging. If shown to be feasible and accurate, our proposed study could substantially impact how we counsel patients with this arrhythmia and how we perform repeat ablation procedures.
Competitiondate
201809
Approvedterm2
2 yrs 0 mth
Pinamesdelim
RAMIREZ, Francisco D
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~